KELLY LYONS: Open Payments
NPI 1538413877 · APPLE VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 82 payments from 16 companies in 2025. Trend: 2023 $1,096 · 2024 $1,554 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 16 | $881 |
| Ardelyx, Inc. | 11 | $314 |
| ABBVIE INC. | 22 | $253 |
| Regeneron Healthcare Solutions, Inc. | 5 | $178 |
| Janssen Biotech, Inc. | 10 | $167 |
| Phathom Pharmaceuticals, Inc. | 3 | $82 |
| GENZYME CORPORATION | 3 | $62 |
| Gilead Sciences, Inc. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
Products named: REZDIFFRA, IBSRELA, DUPIXENT, TREMFYA, MAVYRET, VOQUEZNA, LINZESS, RINVOQ.
Industry payments across CA — which companies pay providers there.
